CNR1 and Duchenne muscular dystrophy: Endocannabinoid signaling at CB1 is involved in DMD onset and progression (Iannotti et al, 2018) and has been suggested to cross‐talk with the gut microbiome (Cani et al, 2016; Manca et al, 2020).